✦ LIBER ✦

Is the inhibition of protein phosphatase 1 and 2A activities a general mechanism of tumor promotion in human cancer development?

✍ Scribed by Hirota Fujiki

Publisher: John Wiley and Sons
Year: 1992
Tongue: English
Weight: 358 KB
Volume: 5
Category: Article
ISSN: 0899-1987
DOI: 10.1002/mc.2940050202

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A functional polymorphism (−1607 1G→2G)

A functional polymorphism (−1607 1G→2G) in the matrix metalloproteinase-1 promoter is associated with development and progression of lung cancer

✍ Li Liu; Jing Wu; Chen Wu; Ying Wang; Rong Zhong; Xinyu Zhang; Wen Tan; Shaofa Ni 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 240 KB

Lactotransferrin: A candidate tumor supp

Lactotransferrin: A candidate tumor suppressor—Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway

✍ Yanhong Zhou; Zhaoyang Zeng; Wenling Zhang; Wei Xiong; Minghua Wu; Yixin Tan; We 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 417 KB 👁 1 views

## Abstract Lactotransferrin (LTF) has been shown to regulate tumorogenesis. However, little is known about the role of LTF in regulating the development of human nasopharyngeal carcinoma (NPC). The aim of our study was to investigate whether LTF could regulate the development of NPC by characteriz

Enhanced local dendritic cell activity a

Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model

✍ Koichiro Saito; Koji Araki; Nishant Reddy; Wei Guang; Bert W. O'Malley Jr; Daqin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract ## Background. Radiofrequency ablation (RFA) is a minimally invasive tumor destruction technique and can provide the antigen source initiating tumor immunity. However, induced immune response is weak and requires additional immunotherapy for optimized RFA treatment against cancer. ##